WBA announced a cash dividend of 0.48 with an ex-date of Feb. 15, 2023
|Bid||37.08 x 1800|
|Ask||37.12 x 800|
|Day's Range||36.92 - 37.75|
|52 Week Range||30.39 - 50.19|
|Beta (5Y Monthly)||0.74|
|PE Ratio (TTM)||7.37|
|Earnings Date||Mar 29, 2023 - Apr 03, 2023|
|Forward Dividend & Yield||1.92 (5.16%)|
|Ex-Dividend Date||Feb 15, 2023|
|1y Target Est||41.32|
Subscribe to Yahoo Finance Plus to view Fair Value for WBA
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $37.09, marking a -1.64% move from the previous day.
In early 2028, pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) will likely be a larger and more diversified business, assuming its foray into primary care goes according to plan. The pharmacy company finds itself in the midst of an attempt to diversify into providing healthcare services like primary care during a time when its top and bottom lines are looking somewhat weak. As you can see, both its quarterly revenue and net income haven't shown much sign of improvement over the last five years.
Republican attorneys general in 20 states warned CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc (NASDAQ: WBA) against mailing abortion pills in their jurisdictions. Also Read: Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow. “We emphasize that it is our responsibility as State Attorneys General to uphold the law and protect the health, safety, and well-being of women and unborn children in our states,” the attorney generals said in lett